BIOMAT Database Logo BIOMAT Database Logo

[Physical therapy with VRP1 in chronic obstructive respiratory tract diseases--results of a multicenter comparative study]. 1993

U H Cegla, and A Retzow
Hufeland Klinik, Bad Ems.

In a multicenter group comparative study with 51 patients suffering from chronic obstructive lung diseases, efficacy and tolerance of physiotherapy with the VRP1 Desitin was investigated. In comparison with the control group (concomitant respiratory physiotherapy) a statistically significant increase in the lung function parameter VC, FEV1 and PEF was demonstrated in the VRP1 Desitin-group after 2 weeks of investigation. Auscultatory findings as well as the clinical symptoms cough, sputum and dyspnea were clearly improved. The patients observed an improvement in their condition and capability.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D001987 Bronchiectasis Persistent abnormal dilatation of the bronchi. Cylindrical Bronchiectasis,Cystic Bronchiectasis,Saccular Bronchiectasis,Varicose Bronchiectasis,Bronchiectases,Bronchiectasis, Cylindrical,Bronchiectasis, Cystic,Bronchiectasis, Saccular,Bronchiectasis, Varicose,Cylindrical Bronchiectases,Cystic Bronchiectases,Saccular Bronchiectases,Varicose Bronchiectases
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

U H Cegla, and A Retzow
[Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
March 1998, Pneumologie (Stuttgart, Germany),
U H Cegla, and A Retzow
[Staged therapy of chronic obstructive respiratory tract diseases. Treatment of chronic obstructive respiratory tract diseases by the established physician].
March 1989, Fortschritte der Medizin,
U H Cegla, and A Retzow
[Physical therapy in obstructive respiratory tract diseases: when dyspnea increases].
July 2003, Pflege Zeitschrift,
U H Cegla, and A Retzow
[Therapy of chronic obstructive diseases of the respiratory tract].
November 1967, La Clinica terapeutica,
U H Cegla, and A Retzow
[Inhalation therapy in chronic obstructive respiratory tract diseases. German Respiratory League].
May 1994, Pneumologie (Stuttgart, Germany),
U H Cegla, and A Retzow
[Osteoporosis in corticoid therapy of patients with chronic obstructive respiratory tract diseases].
January 1985, Zeitschrift fur Erkrankungen der Atmungsorgane,
U H Cegla, and A Retzow
[Therapy of obstructive respiratory tract diseases].
June 1991, Pneumologie (Stuttgart, Germany),
U H Cegla, and A Retzow
[Current problems of corticosteroid therapy in chronic obstructive respiratory tract diseases].
January 1988, Zeitschrift fur arztliche Fortbildung,
U H Cegla, and A Retzow
[Broncholytic inhalation therapy. Double-blind study hexoprenaline orziprenaline in chronic obstructive respiratory tract diseases].
September 1974, Schweizerische medizinische Wochenschrift,
U H Cegla, and A Retzow
[Chronic obstructive respiratory tract diseases: standards and trends of antibiotic therapy].
July 1988, Praxis und Klinik der Pneumologie,
Copied contents to your clipboard!